He is Editor-In-Chief of “Anti-Cancer Agents in Medicinal Chemistry” (Bentham Science Publishers, Q3 in Chemistry, Medicinal) (19/11/2020).
He is Co-Editor of Current Medicinal Chemistry (Bentham Science Publishers, Q2 in Chemistry, Medicinal) (01/3/2021).
He is Co-editor-in-chief of “Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry” (Bentham Science Publishers) (24/5/2016).
He was involved as a Section Editor for “Current Enzyme Inhibition” (Bentham Science Publishers) (01/09/2020-14/06/2021).
He is also a member of the Editorial Board of “Journal of Enzyme Inhibition and Medicinal Chemistry” (Taylor & Francis, Q1 in Chemistry, Medicinal), “Antioxidants” (MDPI, Q1 in Chemistry, Medicinal), “Expert Opinion on Therapeutic Patents” (Taylor & Francis, Q1 in Chemistry, Medicinal), “Bioorganic Chemistry” (Elsevier, Q1 in Chemistry, Organic, Q1 in Biochemistry & Molecular Biology), “Mini-Reviews in Medicinal Chemistry” (Bentham Science Publishers, Q2 in Chemistry, Medicinal), “Antibiotics” (MDPI, Q1 in Pharmacology & Pharmacy, Q2 in Infectious Diseases), “CNS & Neurological Disorders – Drug Targets” (Bentham Science Publishers, Q3 in Pharmacology & Pharmacy, Q3 in Neurosciences) and Scientifica (Hindawi).
He was appointed as Review Editor in Frontiers in Oncology (Section “Cancer Molecular Targets and Therapeutics”, 27/06/21) and in Frontiers in Drug Safety and Regulation (Section “Substance-Based Medical Devices” 31/10/21).
Guest Associate Editor in “Medicinal and Pharmaceutical Chemistry” and Review Editor in “Cancer Molecular Targets and Therapeutics”, “Ethnopharmacology” and “Substance-Based Medical Device” for Frontiers Publisher.